[A study on the penetration of cefmenoxime into bile and gallbladder tissues and the pathological changes of inflamed tissues].
The penetration of cefmenoxime (CMX) into bile and gallbladder tissues was studied. A dose of 2 g CMX was given intravenously to each of patients with gallstones. Concentrations of CMX in the gallbladder tissues were 120.6 +/- 39.8 micrograms/g in normal tissues about 2 hours after the administration and 128.3 +/- 52.3 micrograms/g in inflamed tissues. The penetration of CMX into gallbladder tissue tended to decrease in proportion to the severity of inflammation, but the difference between the 2 groups, normal and inflamed tissues, were not statistically significant. The penetration of CMX into gallbladder tissue was presumed to increase in proportion to increase in the serum concentration of CMX. The result indicated that the achievement of high concentrations of CMX in the serum is important in the treatment of biliary tract diseases.
Tsuburaya
H
H
Ando
Y
Y
Kimizima
I
I
Watanabe
I
I
Abe
R
R
Funayama
T
T
Kawaguchi
Y
Y
D000328:Adult; D000368:Aged; D001646:Bile / Q000378:metabolism*; D001660:Biliary Tract Diseases / Q000188:drug therapy; D015281:Cefmenoxime; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D002764:Cholecystitis / Q000188:drug therapy / Q000473:pathology*; D002769:Cholelithiasis / Q000188:drug therapy; D005260:Female; D005704:Gallbladder / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged
D015281:Cefmenoxime; D002439:Cefotaxime